BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38149470)

  • 1. Preventive effects of caffeine on nicotine plus high-fat diet-induced hepatic steatosis and gain weight: a possible explanation for why obese smokers with high coffee consumption tend to be leaner.
    Lu N; Mei X; Li X; Tang X; Yang G; Xiang W
    Br J Nutr; 2024 Apr; 131(8):1342-1351. PubMed ID: 38149470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
    J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
    Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response.
    Yang Q; Shu F; Gong J; Ding P; Cheng R; Li J; Tong R; Ding L; Sun H; Huang W; Wang Z; Yang L
    J Ethnopharmacol; 2020 Jun; 255():112556. PubMed ID: 31926984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a Low Dose of Caffeine Alone or as Part of a Green Coffee Extract, in a Rat Dietary Model of Lean Non-Alcoholic Fatty Liver Disease without Inflammation.
    Velázquez AM; Roglans N; Bentanachs R; Gené M; Sala-Vila A; Lázaro I; Rodríguez-Morató J; Sánchez RM; Laguna JC; Alegret M
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113993
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zandani G; Anavi-Cohen S; Yudelevich T; Nyska A; Dudai N; Madar Z; Gorelick J
    Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
    Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
    J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polyherbal drug GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits hepatic steatosis and fibroinflammtion in high-fat diet-induced obese mice.
    Lim J; Lee H; Ahn J; Kim J; Jang J; Park Y; Jeong B; Yang H; Shin SS; Yoon M
    J Ethnopharmacol; 2018 Oct; 225():31-41. PubMed ID: 29958960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.
    Cheng K; Song Z; Zhang H; Li S; Wang C; Zhang L; Wang T
    Med Mol Morphol; 2019 Dec; 52(4):187-197. PubMed ID: 30673851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
    Wu L; Liu Y; Zhao Y; Li M; Guo L
    Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress.
    Wei K; Wei Y; Xu W; Lu F; Ma H
    Food Funct; 2022 May; 13(10):5782-5793. PubMed ID: 35537139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
    Lee H; Ahn J; Shin SS; Yoon M
    Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (
    Wu M; Lo TH; Li L; Sun J; Deng C; Chan KY; Li X; Yeh ST; Lee JTH; Lui PPY; Xu A; Wong CM
    Elife; 2023 Aug; 12():. PubMed ID: 37580962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic and therapeutic effects of different doses of vitamin C on high-fat-diet-induced non-alcoholic fatty liver disease in mice.
    Zeng Q; Zhao L; Meng C; Zhao X; Liu Y; Shi R; Han X; Wang T; Li J
    Biomed Pharmacother; 2020 Nov; 131():110792. PubMed ID: 33152949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice.
    Tian J; Cai M; Jin S; Chen Q; Xu J; Guo Q; Yan Z; Han X; Lu H
    Pharm Biol; 2023 Dec; 61(1):647-656. PubMed ID: 37038833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet.
    Coia H; Ma N; Hou Y; Permaul E; Berry DL; Cruz MI; Pannkuk E; Girgis M; Zhu Z; Lee Y; Rodriquez O; Cheema A; Chung FL
    Clin Nutr; 2021 Jan; 40(1):110-119. PubMed ID: 32439267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice.
    Yang F; Huang P; Shi L; Liu F; Tang A; Xu S
    Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention.
    Helal MG; Ayoub SE; Elkashefand WF; Ibrahim TM
    Hum Exp Toxicol; 2018 Sep; 37(9):983-990. PubMed ID: 29249184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.